Grants and Contributions:
Title:
ARP - Use of the Hyperscint platform for in vivo surface dosimetry during radiotherapy treatments
Agreement Number:
1022390
Agreement Value:
$75,000.00
Agreement Date:
Sep 23, 2024 - Mar 28, 2025
Description:
This project will investigate the technological uncertainties involved in using the Hyperscint MD product for in vivo surface dosimetry during external radiotherapy treatments.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2024-2025-Q2-1022390
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
748576287
Recipient Type:
For-profit organization
Recipient's Legal Name:
Medscint inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512